Discover 1,665 paid clinical trials in Colorado. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Colorado offers a variety of paid research opportunities, including paid studies for healthy volunteers and trials for those with specific health needs. Research hubs in Denver, Colorado Springs, and Boulder are actively recruiting participants, providing access to innovative treatments and exceptional medical care.
Filter
1
Filter results
Results: 1,665
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
for
Hypothalamic Obesity,
Location: Boston MA, New York NY, Philadelphia PA, Birmingham AL,
Sponsor: Rhythm Pharmaceuticals, Inc.
Sex: All
Age: 4+
Code: NCT06760546
Phase3, Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
for
Prostate Cancer (Adenocarcinoma)
Location: Saint John, Providence RI, Saint Johnsbury VT,
Sponsor: Canadian Cancer Trials Group
Sex: Male
Age: 18+
Code: NCT06592924
Phase3, Recruiting
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Location: Boston MA, Chicago IL, Aurora CO, Stanford CA,
Sponsor: Sonoma Biotherapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07123038
Recruiting
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
for
Malignant Neoplasm
Location: Boston MA, Valhalla NY, New York NY, New Brunswick NJ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT06941272
Phase1, Phase2, Recruiting
Type 1 Diabetes REst for Metabolic Health
for
Type 1 Diabetes (T1D), Sleep Health
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 14 - 19
Code: NCT06627504
Recruiting
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
for
Major Depressive Disorder
Location: Cedarhurst NY, New York NY, Verdun, Miami FL,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18+
Code: NCT06963021
Phase3, Recruiting
Featured
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: New York NY, New Brunswick NJ, Montreal,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06896916
Phase1, Recruiting
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
for
Staphylococcus Aureus
Location: Ridgewood NY, Jersey City NJ, Bethlehem PA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 55
Code: NCT06749457
Phase1, Phase2, Recruiting
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
for
Cystic Fibrosis (CF)
Location: Boston MA, Richmond VA, Chapel Hill NC, Hollywood FL,
Sponsor: State University of New York at Buffalo
Sex: All
Age: 1 - 11
Code: NCT07048574
Recruiting
Countermeasures to Circadian Misalignment
for
Circadian Rhythm Sleep Disorder of Shift Work Type,
Location: Fort Collins CO
Sponsor: Colorado State University
Sex: All
Age: 18 - 35
Code: NCT04966351
Recruiting
A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
for
Thrombocytopenia, Neonatal Alloimmune
Location: Philadelphia PA, Rochester NY, Chapel Hill NC,